Guangdong Zhongsheng Pharmaceutical Co Ltd Total Liabilities
Guangdong Zhongsheng Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has total liabilities worth CN¥1.04 Billion CNY (≈ $152.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 002317 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Total liabilities of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. This chart illustrates how Guangdong Zhongsheng Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Guangdong Zhongsheng Pharmaceutical Co L (002317) investment intensity to see how much of total assets are deployed in long-term investments.
Guangdong Zhongsheng Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangdong Zhongsheng Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623
|
China | CN¥3.55 Billion |
|
IGB Real Estate Investment Trust
KLSE:5227
|
Malaysia | RM2.48 Billion |
|
MiTAC Holdings Corp
TW:3706
|
Taiwan | NT$44.14 Billion |
|
Beijing Capital Co Ltd
SHG:600008
|
China | CN¥69.03 Billion |
|
Sejong Telecom Inc
KQ:036630
|
Korea | ₩182.92 Billion |
|
Levima Advanced Materials Corp
SHE:003022
|
China | CN¥17.85 Billion |
|
Constellium SE
F:3OK
|
Germany | €4.82 Billion |
|
WisdomTree Inc.
NYSE:WT
|
USA | $1.23 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Guangdong Zhongsheng Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Guangdong Zhongsheng Pharmaceutical Co L (002317) total assets.
Liquidity & Leverage Metrics
Guangdong Zhongsheng Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Guangdong Zhongsheng Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Zhongsheng Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual total liabilities of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.54 Billion ≈ $225.84 Million |
-20.15% |
| 2023-12-31 | CN¥1.93 Billion ≈ $282.84 Million |
-1.33% |
| 2022-12-31 | CN¥1.96 Billion ≈ $286.64 Million |
+43.63% |
| 2021-12-31 | CN¥1.36 Billion ≈ $199.57 Million |
+18.64% |
| 2020-12-31 | CN¥1.15 Billion ≈ $168.22 Million |
-16.22% |
| 2019-12-31 | CN¥1.37 Billion ≈ $200.78 Million |
+6.08% |
| 2018-12-31 | CN¥1.29 Billion ≈ $189.27 Million |
+14.90% |
| 2017-12-31 | CN¥1.13 Billion ≈ $164.73 Million |
+40.50% |
| 2016-12-31 | CN¥801.23 Million ≈ $117.24 Million |
-34.57% |
| 2015-12-31 | CN¥1.22 Billion ≈ $179.18 Million |
+200.39% |
| 2014-12-31 | CN¥407.63 Million ≈ $59.65 Million |
+71.24% |
| 2013-12-31 | CN¥238.04 Million ≈ $34.83 Million |
+58.25% |
| 2012-12-31 | CN¥150.41 Million ≈ $22.01 Million |
+62.55% |
| 2011-12-31 | CN¥92.54 Million ≈ $13.54 Million |
-3.13% |
| 2010-12-31 | CN¥95.53 Million ≈ $13.98 Million |
-11.92% |
| 2009-12-31 | CN¥108.46 Million ≈ $15.87 Million |
-23.90% |
| 2008-12-31 | CN¥142.53 Million ≈ $20.86 Million |
-14.74% |
| 2007-12-31 | CN¥167.17 Million ≈ $24.46 Million |
+9.32% |
| 2006-12-31 | CN¥152.93 Million ≈ $22.38 Million |
-- |
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.